EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ketoanalogues of Essential Amino Acids in Chronic Kidney Disease: From Biochemical Rationale to Conditions for Clinical Effectiveness

Adamasco Cupisti iD, Claudia D'Alessandro iD, Vincenzo Panichi, Diego Moriconi iD, Domenico Giannese iD

Nutrients · 2026

DOI: 10.3390/nu18193157 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2026. Verfasst von Adamasco Cupisti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy. Hauptthemen laut MEDLINE: Amino Acids, Essential, Renal Insufficiency, Chronic, Diet, Protein-Restricted, Keto Acids. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein restriction is an established nutritional intervention for selected adults with non-dialysis chronic kidney disease (CKD); a supplemented very-low-protein diet (sVLPD) combines marked protein restriction with essential amino acids and their nitrogen-free keto- and hydroxyanalogues (KAs). KAs may accept amino groups and regenerate essential amino acids while limiting exogenous nitrogen, but reversible transamination competes with irreversible oxidative decarboxylation. This narrative review integrates the biochemical pharmacology of KA/EAA mixtures with the clinical conditions required for effectiveness. Controlled and pragmatic trials are contrasted to distinguish efficacy under selected, adherent conditions from effectiveness in routine care. Safe implementation requires achieved protein restriction, adequate non-protein energy intake, correction of persistent metabolic acidosis, metabolic stability, administration with meals, appropriate dosing and structured monitoring; however, the specific effects of these conditions on in vivo KA disposition have not been quantified in advanced CKD. KA/EAA-supplemented VLPD may delay kidney replacement therapy in appropriately selected and supervised patients, but the supplement should be prescribed as part of a complete nutritional strategy rather than as an autonomous drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amino Acids, EssentialRenal Insufficiency, ChronicDiet, Protein-RestrictedKeto AcidsDietary SupplementsHumansTreatment OutcomeAcidosis

Stichwörter der Autor:innen

chronic kidney diseaseessential amino acidsketoacidsketoanaloguesmetabolic acidosisnitrogen balanceprotein–energy wastingvery-low-protein diet

Substanzen

Amino Acids, EssentialKeto Acids

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy.

ORCID-Profile: Adamasco Cupisti, Claudia D'Alessandro, Diego Moriconi, Domenico Giannese

Zitieren

APA

Cupisti, A., D'Alessandro, C., Panichi, V., Moriconi, D., & Giannese, D. (2026). Ketoanalogues of Essential Amino Acids in Chronic Kidney Disease: From Biochemical Rationale to Conditions for Clinical Effectiveness. Nutrients. https://doi.org/10.3390/nu18193157

Vancouver

Cupisti A, D'Alessandro C, Panichi V, Moriconi D, Giannese D. Ketoanalogues of Essential Amino Acids in Chronic Kidney Disease: From Biochemical Rationale to Conditions for Clinical Effectiveness. Nutrients. 2026. doi:10.3390/nu18193157

BibTeX
@article{Cupisti2026,
  author = {Cupisti, Adamasco and D'Alessandro, Claudia and Panichi, Vincenzo and Moriconi, Diego and Giannese, Domenico},
  title = {Ketoanalogues of Essential Amino Acids in Chronic Kidney Disease: From Biochemical Rationale to Conditions for Clinical Effectiveness},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18193157}
}
Kostenlos starten →